SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy

      Highlights

      • SARS-CoV-2 vaccinations cause SFN
      • GBS should be diagnosed according to the Brighton criteria

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Neuroimmunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Min Y.G.
        • Ju W.
        • Ha Y.E.
        • Ban J.J.
        • Lee S.A.
        • Sung J.J.
        • Shin J.Y.
        Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
        J Neuroimmunol. 2021 Aug 8; 359: 577691https://doi.org/10.1016/j.jneuroim.2021.577691
        • Waheed W.
        • Carey M.E.
        • Tandan S.R.
        • Tandan R.
        Post COVID-19 vaccine small fiber neuropathy.
        Muscle Nerve. 2021 Jul; 64: E1-E2https://doi.org/10.1002/mus.27251